Expanding targeted therapy to NRAS-mutated melanoma

Lancet Oncol. 2013 Mar;14(3):186-8. doi: 10.1016/S1470-2045(13)70054-8. Epub 2013 Feb 13.

Authors

Geoffrey T Gibney¹, Jeffrey S Weber

Affiliation

¹ Department of Cutaneous Oncology and Melanoma Research Center of Excellence, Moffitt Cancer Center, Tampa, FL 33612, USA.

PMID: 23414591
DOI: 10.1016/S1470-2045(13)70054-8

No abstract available

Publication types

Comment

MeSH terms

Benzimidazoles / administration & dosage*
Female
Humans
Male
Melanoma / drug therapy*
Protein Kinase Inhibitors*
Proto-Oncogene Proteins B-raf*

Substances

Benzimidazoles
Protein Kinase Inhibitors
binimetinib
BRAF protein, human
Proto-Oncogene Proteins B-raf